Axsome Therapeutics, Inc. (AXSM) Financials

AXSM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 588.2 million 397.3 million
2023-09-30 600.9 million 331.3 million
2023-06-30 611.6 million 332.8 million
2023-03-31 389.2 million 277.4 million

AXSM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -30.4 million 18.9 million
2023-09-30 -53.9 million 14.8 million
2023-06-30 -55.5 million 15.9 million
2023-03-31 -5.9 million 12.9 million

AXSM Net Income

No data available :(

AXSM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 386.2 million - 8.3 million
2023-09-30 416.6 million - 8.1 million
2023-06-30 437.1 million 176.8 million 7.9 million
2023-03-31 246.5 million 147.6 million 108000

AXSM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 47.3 million
2023-09-30 47.1 million
2023-06-30 43.7 million
2023-03-31 43.5 million

AXSM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 7000 30.8 million 86.8 million -
2023-09-30 371000 28.8 million 55.1 million 28.1 million
2023-06-30 133000 20.6 million 52.2 million 26.7 million
2023-03-31 71000 17.8 million 52.8 million 21.4 million

AXSM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 71.5 million 7.4 million
2023-09-30 57.8 million 6.5 million
2023-06-30 46.7 million 4.6 million
2023-03-31 94.6 million 7.6 million

AXSM

Price: $74.80

52 week price:
55.02
98.40

Earnings Per Share: -5.27 USD

P/E Ratio: -20.31

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1.9 million

Ebitda: -6.3 million

Market Capitalization: 3.4 billion

Links: